NEW YORK (GenomeWeb News) – SuperArray Bioscience has licensed gene-silencing intellectual property from the Carnegie Institution, the firm said today.
 
SuperArray will use Carnegie’s technology to offer RNAi-based gene silencing products for studies including gene-specific siRNA and DNA-based RNAi expressing short hairpin RNA. It also has the right to pass on the technology to end users performing DNA-based RNA interference, said SuperArray.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sep
12
Sponsored by
PerkinElmer

This webinar will cover recent advances in the use of CRISPR for generating animal models and cell lines.